Medicine guide
WYNZORA
As listed in the register: WYNZORA
0.5 mg + 0.05 mg · cream
- Prescription only
- Skin
- Active substance
- Betamethasone (Betamethasone Dipropionate) + Calcipotriol
- Used in
- Skin
- Made by
- Knight Therapeutics Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupSkinD05AX52
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Knight Therapeutics Inc. |
|---|---|
| Active substance | Betamethasone (Betamethasone Dipropionate) + Calcipotriol |
| Used in | Skin |
| Strength | 0.5 mg + 0.05 mg |
| Form | cream |
| Classification | D05AX52 · Skin |
| Route | topical |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02563010 |
| DPD drug code | 106584 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Betamethasone (Betamethasone Dipropionate) + Calcipotriol